Table IV.
Association between COL5A1 and ER, PR, P53, HER-2 and Ki-67 expression in breast cancer.
| COL5A1 | |||||
|---|---|---|---|---|---|
| Factors | Cases | Low expression | High expression | χ2 | P-value |
| ER | 0.247 | 0.619 | |||
| Negative | 45 | 3 | 42 | ||
| Positive | 91 | 10 | 81 | ||
| PR | 0.247 | 0.619 | |||
| Negative | 45 | 3 | 42 | ||
| Positive | 91 | 10 | 81 | ||
| HER-2 (128 cases) | 0.05 | 0.823 | |||
| Negative | 98 | 9 | 89 | ||
| Positive | 30 | 3 | 27 | ||
| P53 | 0.003 | 0.957 | |||
| Negative | 88 | 9 | 79 | ||
| Positive | 48 | 4 | 44 | ||
| Ki-67 | 0.158 | 0.691 | |||
| <14% | 21 | 2 | 19 | ||
| ≥14% | 115 | 11 | 104 | ||
ER, estrogen; PR, progesterone; HER-2, human epidermal growth factor receptor-2; COL5A1, collagen type V α-1 chain.